Abstract:Background A significant relationship exists between atherosclerotic cardiovascular disease (ASCVD) and non-high-density lipoprotein cholesterol (non-HDL-C). However, the relationship between non-HDL cholesterol levels and coronary artery disease in patients with acute coronary syndrome (ACS) remains under-researched and poorly understood. Therefore, this study aimed to explore the association between non-HDL-C and coronary artery disease in individuals with ACS. Methods This single-centre retrospective cross-sectional study included 1695 patients with ACS who underwent percutaneous coronary intervention at Zunyi Medical University's Affiliated Hospital from May 2019 to May 2023. The patients were categorised into three groups based on non-HDL cholesterol tertiles. The severity of coronary artery disease was assessed using the Gensini score, and patients were categorised into high and low Gensini score groups. Logistic regression models, including multifactorial adjustments, were used to analyse the association between non-HDL-C levels and high Gensini scores. Results After adjusting for potential risk factors, multifactorial logistic regression (odds ratio [OR] = 1.20; 95% confidence interval [CI] = 1.10–1.31; p < 0.001) revealed that non-HDL-C was an independent risk factor for high Gensini scores. After subgrouping based on age, sex, and glucose metabolic status, non-HDL-C remained an independent risk factor for high Gensini scores in these subgroups. Restricted cubic spline analysis revealed that a higher non-HDL-C level was associated with a greater the risk of having a high Gensini score. Receiver operating characteristic curve analysis revealed that non-HDL-C was incrementally predictive of high Gensini scores in patients with ACS. Conclusions Non-HDL-C is dose-dependently associated with the severity of coronary artery disease in patients with ACS. These findings suggest the potential of non-HDL-C in predicting its severity, supporting its use as a cost-effective and accessible marker for assessing coronary artery disease risk.

Changes of Serum Oxidized Low-Density Lipoprotein in Patients with Acute and Non-Acute Coronary Artery Disease

[Value of Serum Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 (LOX-1) and LOX-1 Mrna in Peripheral Mononuclear Cells in Early Diagnosis of Acute Coronary Syndrome].

[Correlation of Autoantibodies Against Oxidized Low Density Lipoprotein and Its Immune Complex with Coronary Artery Disease]

Association Between Non-High-density Lipoprotein Cholesterol and Coronary Artery Disease in Patients with Acute Coronary Syndrome: a Single-Centre Retrospective Cross-Sectional Analysis

Relationship Between Autoantibodies Against Oxidized Low-Density Lipoprotein and High-Sensitivity C-reactive Protein in Patients with Coronary Artery Disease

Analysis of correlation between oxidized low density lipoprotein and thrombus precursor protein with acute cerebral infarction

The Changes of the Levels of Plasma Oxidized Low Density Lipoprotein, High-Sensitivity C-Reactive Protein and its Relation to the Endothelial Injury in Patients with Acute Coronary Syndrome

Expression of CD40 and CD40L on peripheral blood mononuclear cells in patients with acute coronary syndromes

Clinical Significance of the Changes of Plasma Adiponectin Levels in Patients with Coronary Artery Disease

The Changes of Secretory Type Ⅱ Phospholipase A2 in Coronary Heart Disease and Its Relationship with High Sensifive-C Reactive Protein

Study Of The Correlation Between Blood Lipid Levels And The Severity Of Coronary Atherosclerosis In A Chinese Population Sample

Clinical significance of serum interleukin-18 (IL-18) and matrix metalloproteinase-(MMP-9) on acute coronary syndrome

[Investigation on Levels of Serum Lipids among 602 Patients Who Had Undergone Coronary Angiography in Zheijian Province].

The Level of Serum Antibody Against Oxidized Low Density Lipoprotein is Increased in Patients with Unstable Angina

Effects of Different Doses of Rosuvastatin on High-sensitivity C-reactive Protein(hs-CRP) and Interleukin-6 (IL-6) in Patients with Acute Coronary Syndrome.

Detection of Blood Serum Oxidized Low Density Lipoprotein Antibody in Patients with Acute Cerebrovascular Ischemia

A sensitive chemiluminescence imaging immunoassay for simultaneous detection of serum oxidized lipoprotein(a) and low density lipoprotein.

Development of ELISA for oxidized,malondialdehyde-modified LDL and clinical value

Measurement of oxidized lipoprotein (a) in patients with acute coronary syndromes and stable coronary artery disease by 2 ELISAs: using different capture antibody against oxidized lipoprotein (a) or oxidized LDL.

Change of Plasma Oxidized Low-Density Lipoprotein Level Predicts Clinical Outcome at 90 Days for Patients with Acute Ischemic Stroke

Value of serum lipoprotein(a) measurement in patients with acute coronary syndrome